Combining oxymatrine or matrine with lamivudine increased its antireplication effect against the hepatitis B virus in vitro

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Ma, Zhi Jie ^a,b   Li, Qi ^a   Wang, Jia Bo ^a   Zhao, Yan Ling ^a   Zhong, Yan Wei ^a   Bai, Yun Feng ^a   Wang, Rui Lin ^a   Li, Jian Yu ^a   Yang, Hui Yin ^a   Zeng, Ling Na ^a   Pu, Shi Biao ^a   Liu, Fei Fei ^a   Xiao, Da Ke ^c   Xia, Xin Hua ^d   Xiao, Xiao He ^a  

^a 302 MILITARY HOSPITAL   (China)

^b CHENGDU UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; MATRINE; OXYMATRINE; VIRUS DNA;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 84874545372     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/186573     Document Type: Article

References (24)

1. Lok A. S. F., McMahon B. J., Chronic hepatitis B: update 2009. Hepatology 2009 50 3 661 662 2-s2.0-70349240414 10.1002/hep.23190
2. Morgan M., Keeffe E. B., Diagnosis and treatment of chronic hepatitis B: 2009 update. Minerva Gastroenterologica e Dietologica 2009 55 1 5 22 2-s2.0-67649337108
3. European Association for the Study of the Liver, EASL clinical practice guidelines: management of chronic hepatitis B virus infection. Journal of Hepatology 2012 57 1 167 185
4. Wiegand J., van Bömmel F., Berg T., Management of chronic hepatitis B: status and challenges beyond treatment guidelines. Seminars in Liver Disease 2010 30 4 361 377 2-s2.0-77958187991 10.1055/s-0030-1267537
5. Liaw Y. F., Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. Journal of Hepatology 2009 51 2 403 410 2-s2.0-67649224111 10.1016/j.jhep.2009.04.003
6. Song L., Clinical observation of treating patient with chronic hepatitis B by lamivudine combined with oxymatrine injection. Journal of Medical Forum 2004 25 11 13
7. Fan R., Clinical study of treating patient with chronic hepatitis B by lamivudine combined with oxymatrine. Chinese Medicine Modern Distance Education of China 2008 6 1 72 73
8. Duan J., Combined application of oxymatrine and lamivudine in treating 60 cases of chronic hepatitis B clinical. Journal of the Fourth Military Medical University 2004 25 4
9. Zhang C., Combined application of oxymatrine and lamivudine in treating 62 cases of chronic hepatitis B. Clinical Medical Engineering 2012 19 6 935 936
10. Xie K., Analysis of clinical therapeutic effect 120 cases of treating patient with chronic hepatitis B by oxymatrine and lamivudine. CJGMTCM 2007 22 10 82 83
11. Liu Z., Therapeutic effect of oxymatrineinjection combined lamivudine for chronic hepatitis B. Journal of Xinxiang Medical College 2003 20 1 41 42
12. Su G., Therapeutic effect of combined lamivudine and oxymatrinefor chronic hepatitis B. Clinical Medicine 2005 25 12 62 64
13. Chen W., Clinical observation of treating patients for 38 cases with chronic hepatitis B by lamivudine combined with oxymatrine. China Journal of Modern Medicine 2009 16 10 62 63
14. Wenqi W., Yunqiao C., Clinical study of lamivudine combined with kurorinone in the treatment of chronic hepatitis B. Journal of Clinical and Experimental Hepatology 2005 8 2 83 84
15. Jia L., Shu-ren L., Therapeutic effect of oxymatrine combined with laminudine in treating patients with chronic hepatits B. Tianjin Journal of Traditional Chinese Medicine 2007 24 2 107 109
16. xiangguo Z., Clinical study of lamivudine combined with matrine in the treatment of chronic hepatitis B. China Clinical Practical Medicine 2009 4 15 143 144
17. xiang G., Clinical study of lamivudine combined with matrine in the treatment of chronic hepatitis B. Progress in Modern Biomedicine 2006 6 7 88 89
18. Gui-ping X., Study on the protective effect of matrine on immune liver injury in rats. Lishizhen Medicine and Materia Medica Research 2007 6 13
19. Zhang J. P., Zhang M., Zhou J. P., Liu F. T., Zhou B., Xie W. F., Gou C., Zhang C., Qian D. H., Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacologica Sinica 2001 22 2 183 186 2-s2.0-0035131870 (Pubitemid 32158359)
20. Hu Z. L., Zhang J. P., Qian D. H., Lin W., Xie W. F., Zhang X. R., Chen W. Z., Effects of matrine on mouse splenocyte proliferation and release of interleukin-1 and -6 from peritoneal macrophages in vitro. Acta Pharmacologica Sinica 1996 17 3 259 261 2-s2.0-0029941963 (Pubitemid 26163295)
21. Cui X., Wang Y., Kokudo N., Fang D., Tang W., Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Bioscience Trends 2010 4 2 39 47 2-s2.0-77956893733
22. guangjun T., tianbao F., mingzeng T., xinhua W., Short-term effect of phyllanthus compound and lamivuding in treating chronic hepatitis B: an observation of 30 cases. Journal of Guangzhou University of Traditional Chinese Medicine 2004 21 4 257 259
23. xiaoquan H., decai Y., hongjing W., Clinical study of phyllanthus compound and lamivuding in treating chronic hepatitis B: an observation of 80 cases. Chinese Journal of Experimental Traditional Medical Formulae 2003 9 6 48 49
24. Mayer L. D., Janoff A. S., Optimizing combination chemotherapy by controlling drug ratios. Molecular Interventions 2007 7 4 216 223 2-s2.0-34548759797 10.1124/mi.7.4.8 (Pubitemid 47437268)